Arrow Mark Colorado Holdings LLC Nevro Corp Transaction History

Arrow Mark Colorado Holdings LLC

$7.59 Billion
Q2 2024

A detailed history of Arrow Mark Colorado Holdings LLC transactions in Nevro Corp stock. As of the latest transaction made, Arrow Mark Colorado Holdings LLC holds 4,289,108 shares of NVRO stock, worth $22.9 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

4,289,108

Previous 2,795,903 53.41%

Holding current value

$22.9 Million

Previous $40.4 Million 10.55%

% of portfolio

0.48%

Previous 0.5%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$7.96 - $13.59 $11.9 Million - $20.3 Million	1,493,205 Added 53.41%	4,289,108 $36.1 Million
Q1 2024 May 15, 2024	SELL	$13.56 - $20.78 $2.92 Million - $4.47 Million	-215,156 Reduced 7.15%	2,795,903 $40.4 Million
Q4 2023 Feb 14, 2024	BUY	$14.18 - $22.31 $16.9 Million - $26.6 Million	1,193,870 Added 65.7%	3,011,059 $64.8 Million
Q2 2023 Aug 14, 2023	BUY	$22.62 - $39.32 $11 Million - $19.1 Million	485,433 Added 36.45%	1,817,189 $46.2 Million
Q1 2023 May 15, 2023	BUY	$30.17 - $41.11 $2.4 Million - $3.27 Million	79,538 Added 6.35%	1,331,756 $48.1 Million
Q4 2022 Feb 14, 2023	BUY	$36.43 - $49.4 $3.69 Million - $5 Million	101,158 Added 8.79%	1,252,218 $49.6 Million
Q3 2022 Nov 14, 2022	SELL	$40.66 - $53.03 $445,348 - $580,837	-10,953 Reduced 0.94%	1,151,060 $53.6 Million
Q2 2022 Aug 15, 2022	BUY	$40.85 - $77.67 $12.5 Million - $23.8 Million	306,574 Added 35.84%	1,162,013 $50.9 Million
Q1 2022 May 16, 2022	BUY	$59.95 - $92.06 $6.78 Million - $10.4 Million	113,107 Added 15.24%	855,439 $61.9 Million
Q4 2021 Feb 14, 2022	BUY	$81.07 - $121.29 $25 Million - $37.4 Million	307,973 Added 70.9%	742,332 $60.2 Million
Q3 2021 Nov 15, 2021	BUY	$101.99 - $166.36 $5.54 Million - $9.03 Million	54,302 Added 14.29%	434,359 $50.6 Million
Q2 2021 Aug 16, 2021	BUY	$141.6 - $179.06 $12.8 Million - $16.2 Million	90,347 Added 31.19%	380,057 $63 Million
Q1 2021 May 17, 2021	SELL	$132.81 - $182.18 $1.75 Million - $2.4 Million	-13,184 Reduced 4.35%	289,710 $40.4 Million
Q4 2020 Feb 16, 2021	SELL	$138.17 - $184.34 $5.27 Million - $7.02 Million	-38,107 Reduced 11.18%	302,894 $52.4 Million
Q3 2020 Nov 16, 2020	SELL	$114.09 - $145.51 $9.6 Million - $12.2 Million	-84,122 Reduced 19.79%	341,001 $47.5 Million
Q2 2020 Aug 14, 2020	SELL	$89.45 - $129.85 $3.2 Million - $4.64 Million	-35,772 Reduced 7.76%	425,123 $50.8 Million
Q1 2020 May 15, 2020	SELL	$70.23 - $144.31 $7.95 Million - $16.3 Million	-113,131 Reduced 19.71%	460,895 $46.1 Million
Q4 2019 Feb 14, 2020	SELL	$76.41 - $117.54 $2.1 Million - $3.23 Million	-27,477 Reduced 4.57%	574,026 $67.5 Million
Q3 2019 Nov 14, 2019	SELL	$61.52 - $91.1 $20 Million - $29.6 Million	-325,253 Reduced 35.1%	601,503 $51.7 Million
Q2 2019 Aug 14, 2019	SELL	$58.04 - $66.99 $55.4 Million - $64 Million	-955,253 Reduced 50.76%	926,756 $60.1 Million
Q1 2019 May 15, 2019	BUY	$35.52 - $62.62 $3.39 Million - $5.98 Million	95,486 Added 5.34%	1,882,009 $118 Million
Q4 2018 Feb 14, 2019	BUY	$35.43 - $56.29 $19.2 Million - $30.5 Million	542,183 Added 43.57%	1,786,523 $69.5 Million
Q3 2018 Nov 14, 2018	BUY	$44.22 - $75.47 $13.2 Million - $22.5 Million	298,348 Added 31.54%	1,244,340 $70.9 Million
Q2 2018 Aug 14, 2018	BUY	$72.38 - $92.5 $13.3 Million - $16.9 Million	183,193 Added 24.02%	945,992 $75.5 Million
Q1 2018 May 15, 2018	SELL	$69.46 - $88.57 $9,029 - $11,514	-130 Reduced 0.02%	762,799 $66.1 Million
Q4 2017 Feb 14, 2018	SELL	$65.94 - $93.31 $64,819 - $91,723	-983 Reduced 0.13%	762,929 $52.7 Million
Q3 2017 Nov 14, 2017	BUY	$80.87 - $91.08 $61.8 Million - $69.6 Million	763,912	763,912 $69.4 Million

Others Institutions Holding NVRO

# of Institutions

162

Shares Held

38M

Call Options Held

44K

Put Options Held

1.69M

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $189M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.

Account

Arrow Mark Colorado Holdings LLC Nevro Corp Transaction History